Medication Considerations

Provide information or materials on the three medications approved by the Food and Drug Administration to treat opioid use disorder.

Effect of Extended-release Naltrexone on Alcohol Consumption: A Systematic Review and Meta-analysis

Reviews seven trials on naltrexone use for alcohol use disorder, finding that it reduces drinking days and heavy drinking days per month, with longer duration of treatment associated with larger reductions

Disulfiram (In: StatPearls)

Provides an overview of disulfiram for alcohol use, including indications, mechanism of action, administration, adverse effects, contraindications, and how to use it within an interprofessional health care team

Bringing Alcohol and Other Drug Research to Primary Care

This course trains providers on evidence-based treatment options for opioid use disorders. It offers 2 continuing medical educations credits.

#VisualAbstract: Acamprosate Found an Effective and Tolerable Interventions for Alcohol Dependence

Visually demonstrates results of a meta-analysis demonstrating that acamprosate was associated with increased odds of abstinence from alcohol

Fact Sheet: Fentanyl Testing to Prevent Overdose

A fact sheet which includes information about fentanyl for both people who use drugs and Healthcare providers.

Syringe Services Programs (SSPs) FAQs

A list of FAQs which pertain to Syringe Services Programs (SSPs), community-based programs that provide access to sterile needles and syringes, facilitate safe disposal of used syringes, and provide and link to other important services and programs.

Telebehavioral Health and Opioid Use Disorder

This section of the Rural Health Toolkit includes examples of innovative telehealth approaches to provide care for people with opioid use disorder in rural communities.

Certification of Opioid Treatment Programs (OTPs)

Learn how your Opioid Treatment Program (OTP) can become accredited and certified to treat substance use disorders.

SAMHSA - Become a Buprenorphine Waivered Practitioner

Learn how to become a buprenorphine waivered practitioner to treat opioid use disorder (OUD).

VA/DoD Clinical Practice Guideline for the Management of Substance Use Disorders

This Clinical Practice Guideline (CPG) provides an evidence-based framework for evaluating, treating, and managing the individual needs of patients with substance use disorders (SUD), including alcohol use disorder, in the VA and DoD. It is intended for use by all VA and DoD healthcare providers.

Subscribe to Medication Considerations